MGO One Seven LLC lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 4.4% during the second quarter, HoldingsChannel reports. The firm owned 4,568 shares of the company’s stock after selling 208 shares during the quarter. MGO One Seven LLC’s holdings in GE HealthCare Technologies were worth $338,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Glenview Trust co raised its stake in shares of GE HealthCare Technologies by 4.4% during the 1st quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after purchasing an additional 139 shares in the last quarter. Silver Oak Securities Incorporated raised its stake in GE HealthCare Technologies by 4.6% in the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after acquiring an additional 140 shares during the period. Chicago Capital LLC raised its stake in GE HealthCare Technologies by 2.2% in the 2nd quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after acquiring an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH raised its stake in GE HealthCare Technologies by 4.2% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after acquiring an additional 143 shares during the period. Finally, Knuff & Co LLC raised its stake in GE HealthCare Technologies by 1.5% in the 1st quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock valued at $829,000 after acquiring an additional 150 shares during the period. Institutional investors own 82.06% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. Barclays assumed coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price target on the stock. BTIG Research increased their price target on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a report on Thursday, September 18th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday, October 14th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $85.20.
GE HealthCare Technologies Stock Performance
Shares of NASDAQ GEHC opened at $74.05 on Monday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The stock’s fifty day moving average price is $74.51 and its two-hundred day moving average price is $72.03. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The firm has a market cap of $33.81 billion, a price-to-earnings ratio of 15.17, a P/E/G ratio of 2.83 and a beta of 1.13.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is 2.87%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?
- How to Calculate Inflation Rate
- Snap-on Incorporated: Snap It Up Quick, New Highs Will Come Soon
- ETF Screener: Uses and Step-by-Step Guide
- As Global Renewables Surpass Coal, This ETF Offers Smart Exposure
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.